Align Corp (ALGN) Enterprise Value to EBITDA Ratio
Align Technology, Inc. (ALGN) combines orthodontic expertise with Silicon Valley innovation to create cutting-edge systems. Market dominance is driven by a unique database of 3D scans and AI-driven planning. However, falling consumer demand is forcing the company to implement discounts. The EV/EBITDA valuation multiple demonstrates current capital resilience, with the metric recorded at 11.55.
Comprehensive metric breakdowns and analytics for aligntech.com (ALGN)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
ALGN - Net Financial Result|Projected Future Earnings Align Technology, Inc.|ALGN - Price to Earnings Ratio|Forward P/E Multiple Align Technology, Inc.|ALGN - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Align Corp|ALGN - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Align Technology|ALGN - Earnings per share for the trailing year|Quarterly EPS earnings growth aligntech.com|ALGN - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Align Technology, Inc.
Analysis of all company metrics:Align Technology Inc ALGN
This metric relates the total enterprise value, including debt obligations, to its operating profit before depreciation and amortization. The metric objectively assesses asset value by excluding the impact of tax policy and capital structure. This is critical for Align Technology, Inc. (ALGN), as demand for aesthetic dentistry is volatile and depends on consumer purchasing power. By analyzing the EV/EBITDA multiple chart, an investor can determine the real value of the company relative to its current efficiency.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|GMED (Globus Medical Corp) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation TMDX (transmedics.com)|Enterprise Value to EBITDA Ratio ATEC (Alphatec Holdings, Inc.)|AORT (artivion.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Enovis ENOV|IART - Enterprise Value to EBITDA Ratio|Motiva - EV/EBITDA Multiple|Company Value to EBITDA iLet Bionic Pancreas|IRMD: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation EMBC|TNDM (Tandem Diabetes Care, Inc.) - EV/EBITDA Multiple|AxoGen Inc (AXGN) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple SIBN|Enterprise Value to EBITDA Ratio Orthofix Corp OFIX|EV/EBITDA Multiple BVS (Bioventus Inc.)|EV/EBITDA Multiple OrthoPediatrics Corp KIDS|TMCI - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|CARL (Carlsmed Corp) - Enterprise Value to EBITDA Ratio|RxSight Ophthalmic - Business Value to Operating Income Before Depreciation|CLPT (ClearPoint Neuro Inc.) - EV/EBITDA Multiple|Company Value to EBITDA stereotaxis.com STXS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Neuronetics (STIM)|Sight Sciences Inc. (SGHT) - Enterprise Value to EBITDA Multiple|Orchestra BioMed - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Anika Therapeutics Inc. ANIK|InspireMD, Inc. - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical International ZJYL|vivani.com (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NeuroOne Corp|Enterprise Value to EBITDA Ratio Modular Med (MODD)|EV/EBITDA Multiple MYO|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics, Inc. VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical Inc - Enterprise Value to Operating Income Before Depreciation Ratio|LFWD: EV/EBITDA Multiple|Autonomix Medical (AMIX) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization INVO Fertility|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization BBLG|EV/EBITDA Multiple AXNX|Total Company Value to Operating Income Before Depreciation Ratio Biolase Inc.|EV/EBITDA Multiple DYNT (Dynatronics)|Enterprise Value to EBITDA Multiple Paragon 28 Inc.|INVO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
